CATX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 15:45):

Stats
Today's Volume	4.09M
Average Volume	4.37M
Market Cap	1.07B
EPS	$0 ( 2024-02-15 )
Next earnings date	( $-0.0300 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-12.96
ATR14	$0.00700 (0.39%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-23	Austin Mark John	Sell	30 000	Stock option (right to buy)
2024-04-23	Austin Mark John	Buy	30 000	Common stock
2024-03-06	Lantheus Alpha Therapy, Llc	Buy	60 431 039	Common Stock
2024-01-30	Williamson Robert F Iii	Buy	3 500	Common Stock
2024-01-30	Williamson Robert F Iii	Buy	42 879	Common Stock

INSIDER POWER
99.89
Last 19 transactions
Buy: 61 056 120 \| Sell: 30 000

Volume Correlation

Long: 0.06 (neutral)

Short: -0.70 (moderate negative)

Signal:(56.985) Neutral

Perspective Therapeutics, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Perspective Therapeutics, Correlation - Currency/Commodity

-0.68
( moderate negative )

-0.58
( weak negative )

0.00
( neutral )

-0.70
( moderate negative )

0.00
( neutral )

0.80
( strong )

Perspective Therapeutics, Financials

Annual	2022
Revenue:	$7.10M
Gross Profit:	$1.63M (23.00 %)
EPS:	$-0.100

FY	2022
Revenue:	$7.10M
Gross Profit:	$1.63M (23.00 %)
EPS:	$-0.100

FY	2022
Revenue:	$10.80M
Gross Profit:	$4.62M (42.76 %)
EPS:	$-0.0504

Financial Reports:

No articles found.

Perspective Therapeutics,

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.